Regulatory Requirements for the Development of Chirally Active Drugs

  • Shah R
  • Branch S
N/ACitations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The views expressed in this chapter are those of the authors and do not necessarily represent the views or the opinions of Medicines Control Agency, other regulatory authorities or any of their advisory committees.

Cite

CITATION STYLE

APA

Shah, R. R., & Branch, S. K. (2003). Regulatory Requirements for the Development of Chirally Active Drugs (pp. 379–399). https://doi.org/10.1007/978-3-642-55842-9_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free